The POU5F1 antibody targets the POU5F1 protein, a transcription factor critical for embryonic stem cell pluripotency and self-renewal. Its role extends to cancer stem-like cells (CSLCs), where it promotes tumorigenesis and metastasis. This article synthesizes data on antibody specifications, applications, and research findings, drawing from diverse sources .
POU5F1, also known as OCT4, is a homeodomain transcription factor encoded by the POU5F1 gene. It regulates genes like NANOG and UTF1 to maintain embryonic stem cell (ESC) pluripotency . In cancer, POU5F1 drives CSCL self-renewal and metastasis by upregulating matrix metalloproteinases (MMPs) and activating epithelial-to-mesenchymal transition (EMT) .
The antibody is used in:
Western Blot (WB): Detects POU5F1 expression in cancer cells and ESCs .
Immunoprecipitation (IP): Identifies POU5F1 interactions with transcriptional partners (e.g., SOX2) .
Immunocytochemistry (ICC): Visualizes nuclear localization in stem cells .
Tumor Growth: POU5F1 overexpression enhances proliferation and metastasis in gastric cancer (GC) , lung adenocarcinoma , and sarcomas .
Mechanisms:
Therapeutic Targeting: All-trans retinoic acid (ATRA) inhibits POU5F1-induced EMT and metastasis .
Knockdown Experiments: POU5F1 siRNA reduces CSCL invasion and induces senescence .
Biomarker Potential: Co-expression of POU5F1 and MMP-2 correlates with poor prognosis in lung adenocarcinoma .